Alx Oncology (ALXO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.00, +11.73% vs the prior close of $0.89.
- Volume 3.71M shares, 3.1x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
ALXO jumps 11.7% to $1.00 on 3.1x normal volume. Closed at $1.00, +11.73% vs the prior close of $0.89. Day range $0.86–$1.02, opened at $0.91.
ALXO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ALXO jumps 11.7% to $1.00 on 3.1x normal volume
- Closed at $1.00, +11.73% vs the prior close of $0.89. Day range $0.86–$1.02, opened at $0.91.
- Volume was 3.71M shares, 3.1x its 50-day average of 1.22M — unusually heavy trading.
- Price is -41.2% vs its 50-day average ($1.70) and -45.3% vs its 200-day average ($1.83).
- 52-week range $0.86–$2.66; today's close sits at 8% of that range, 62.4% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — ALXO slides 8.7% to $0.89, a 52-week low on 2.2x normal volume
- Closed at $0.89, -8.67% vs the prior close of $0.98. Day range $0.89–$0.99, opened at $0.99.
- Volume was 2.57M shares, 2.2x its 50-day average of 1.17M — unusually heavy trading.
- Price is -47.9% vs its 50-day average ($1.72) and -51.1% vs its 200-day average ($1.83).
- 52-week range $0.89–$2.66; today's close sits at 1% of that range, 66.4% below the 52-week high.
Oct 13, 2026 — ALXO slides 22.2% to $0.98, a 52-week low
- Closed at $0.98, -22.22% vs the prior close of $1.26. Day range $0.98–$1.26, opened at $1.26.
- Volume was 1.00M shares, 0.9x its 50-day average of 1.16M.
- Price is -43.7% vs its 50-day average ($1.74) and -46.5% vs its 200-day average ($1.83).
- 52-week range $0.98–$2.66; today's close sits at 0% of that range, 63.2% below the 52-week high.
Oct 12, 2026 — ALXO rises 0.8% to $1.26, 4 up days in a row
- Closed at $1.26, +0.80% vs the prior close of $1.25. Day range $1.18–$1.27, opened at $1.21.
- Volume was 894.80K shares, 0.8x its 50-day average of 1.16M.
- Price is -28.4% vs its 50-day average ($1.76) and -31.3% vs its 200-day average ($1.83).
- 52-week range $1.05–$2.66; today's close sits at 13% of that range, 52.6% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — ALXO jumps 5.9% to $1.25, 3 up days in a row
- Closed at $1.25, +5.93% vs the prior close of $1.18. Day range $1.15–$1.29, opened at $1.16.
- Volume was 1.22M shares, 1.1x its 50-day average of 1.14M.
- Price is -29.5% vs its 50-day average ($1.77) and -31.8% vs its 200-day average ($1.83).
- 52-week range $1.05–$2.66; today's close sits at 12% of that range, 53.0% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — ALXO jumps 4.4% to $1.18
- Closed at $1.18, +4.42% vs the prior close of $1.13. Day range $1.08–$1.20, opened at $1.13.
- Volume was 1.81M shares, 1.6x its 50-day average of 1.12M.
- Price is -34.0% vs its 50-day average ($1.79) and -35.7% vs its 200-day average ($1.84).
- 52-week range $1.05–$2.66; today's close sits at 8% of that range, 55.6% below the 52-week high.
Oct 7, 2026 — ALXO rises 1.8% to $1.13
- Closed at $1.13, +1.80% vs the prior close of $1.11. Day range $1.10–$1.15, opened at $1.11.
- Volume was 764.20K shares, 0.7x its 50-day average of 1.11M.
- Price is -37.3% vs its 50-day average ($1.80) and -38.5% vs its 200-day average ($1.84).
- 52-week range $1.05–$2.66; today's close sits at 5% of that range, 57.5% below the 52-week high.
Oct 6, 2026 — ALXO slides 8.3% to $1.11, a 6-month low, 4 down days in a row
- Closed at $1.11, -8.26% vs the prior close of $1.21. Day range $1.09–$1.21, opened at $1.19.
- Volume was 1.01M shares, 0.9x its 50-day average of 1.10M.
- Price is -39.0% vs its 50-day average ($1.82) and -39.6% vs its 200-day average ($1.84).
- 52-week range $1.05–$2.66; today's close sits at 4% of that range, 58.3% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — ALXO dips 0.8% to $1.21, a 6-month low, 3 down days in a row
- Closed at $1.21, -0.82% vs the prior close of $1.22. Day range $1.14–$1.27, opened at $1.22.
- Volume was 1.79M shares, 1.7x its 50-day average of 1.08M.
- Price is -34.2% vs its 50-day average ($1.84) and -34.2% vs its 200-day average ($1.84).
- 52-week range $1.05–$2.66; today's close sits at 10% of that range, 54.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ALXO slides 6.2% to $1.22, a 6-month low on 2.2x normal volume
- Closed at $1.22, -6.15% vs the prior close of $1.30. Day range $1.21–$1.38, opened at $1.30.
- Volume was 2.26M shares, 2.2x its 50-day average of 1.04M — unusually heavy trading.
- Price is -34.2% vs its 50-day average ($1.85) and -33.7% vs its 200-day average ($1.84).
- 52-week range $1.05–$2.66; today's close sits at 11% of that range, 54.1% below the 52-week high.
ALXO latest news & SEC filings
Every SEC filing by or about ALXO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lettmann Jason sold 2,230 shares at $1.93 (≈$4.30K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wong Shelly sold 573 shares at $1.93 (≈$1.11K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$17.97M (prior year -$25.95M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.13 (prior year -$0.49) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wong Shelly sold 1,404 shares at $2.04 (≈$2.86K) on Jul 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Things to know before you trade ALXO
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 8, 2026, Feb 27, 2026, Nov 7, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.84% (largest 22.2%). That is a volatile stock.
- Liquidity: about 1.69M shares (≈$1.69M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.00 vs a range of $0.86–$2.66 (8% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 7 sales; latest: Jason Lettmann sold 2,230 shares on Aug 17, 2026.
- Latest filings: 8-K Oct 15, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 138.28M shares outstanding (Jul 30, 2026), +158.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ALXO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.91 | 1.02 | 0.86 | 1.00 | 3.71M |
| Oct 14, 2026 | 0.99 | 0.99 | 0.89 | 0.89 | 2.57M |
| Oct 13, 2026 | 1.26 | 1.26 | 0.98 | 0.98 | 1.00M |
| Oct 12, 2026 | 1.21 | 1.27 | 1.18 | 1.26 | 894.80K |
| Oct 9, 2026 | 1.16 | 1.29 | 1.15 | 1.25 | 1.22M |
| Oct 8, 2026 | 1.13 | 1.20 | 1.08 | 1.18 | 1.81M |
| Oct 7, 2026 | 1.11 | 1.15 | 1.10 | 1.13 | 764.20K |
| Oct 6, 2026 | 1.19 | 1.21 | 1.09 | 1.11 | 1.01M |
| Oct 5, 2026 | 1.22 | 1.27 | 1.14 | 1.21 | 1.79M |
| Oct 2, 2026 | 1.30 | 1.38 | 1.21 | 1.22 | 2.26M |
| Oct 1, 2026 | 1.37 | 1.42 | 1.28 | 1.30 | 1.48M |
| Sep 30, 2026 | 1.34 | 1.46 | 1.31 | 1.39 | 1.34M |
| Sep 29, 2026 | 1.37 | 1.45 | 1.33 | 1.35 | 1.77M |
| Sep 28, 2026 | 1.32 | 1.45 | 1.30 | 1.39 | 1.96M |
| Sep 25, 2026 | 1.34 | 1.37 | 1.29 | 1.31 | 1.17M |
| Sep 24, 2026 | 1.46 | 1.49 | 1.34 | 1.36 | 1.20M |
| Sep 23, 2026 | 1.59 | 1.60 | 1.43 | 1.47 | 1.28M |
| Sep 22, 2026 | 1.68 | 1.68 | 1.60 | 1.60 | 652.80K |
| Sep 21, 2026 | 1.72 | 1.72 | 1.65 | 1.66 | 849.50K |
| Sep 18, 2026 | 1.74 | 1.75 | 1.67 | 1.70 | 5.06M |
About Alx Oncology
Alx Oncology (ALXO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1810182.
ALXO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel J. Curran | Director | Jan 21, 2026 |
| Corey S Goodman | Director | Feb 4, 2026 |
| J. Scott Garland | Director | Jan 21, 2026 |
| Rekha Hemrajani | Director | Jan 21, 2026 |
| Jason Lettmann | CHIEF EXECUTIVE OFFICER | Aug 18, 2026 |
| Alan B. Sandler | Director | Jan 21, 2026 |
| Chris H Takimoto | Director | Jan 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Barbara Klencke | Chief Medical Officer | Apr 17, 2026 |
| Jeff E. Knight | Chief Dev & Operating Officer | Apr 17, 2026 |
| Jason Lettmann | CHIEF EXECUTIVE OFFICER | Aug 18, 2026 |
| Shelly Pinto | SVP, FINANCE AND CAO | Mar 23, 2026 |
| Harish Shantharam | Chief Financial Officer | Jan 28, 2026 |
| Shelly Wong | SVP, FINANCE AND CAO | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Jason Lettmann | Sale | 2,230 | $1.93 |
| Aug 17, 2026 | Shelly Wong | Sale | 573 | $1.93 |
| Jul 1, 2026 | Shelly Wong | Sale | 1,404 | $2.04 |
| Mar 19, 2026 | Jason Lettmann | Sale | 12,311 | $2.17 |
| Mar 19, 2026 | Shelly Pinto | Sale | 903 | $2.17 |
| Feb 18, 2026 | Shelly Pinto | Sale | 565 | $2.27 |
| Feb 2, 2026 | Corey S Goodman | Buy | 3,184,713 | $1.57 |
| Jan 6, 2026 | Shelly Pinto | Sale | 3,925 | $1.11 |
ALXO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-101.69M | -1.90 | $-84.14M |
| Dec 31, 2024 | — | $-134.85M | -2.58 | $-121.91M |
| Dec 31, 2023 | — | $-160.81M | -3.74 | $-130.36M |
| Dec 31, 2022 | $0 | $-123.48M | -3.03 | $-89.22M |
| Dec 31, 2021 | $0 | $-83.46M | -2.07 | $-68.10M |
Latest balance sheet: total assets $160.82M, total liabilities $24.63M, cash $22.69M (as of Jun 30, 2026).
ALXO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $2.11 |
| May 8, 2026 | 8-K Item 2.02 (results) | $2.08 |
| Feb 27, 2026 | 8-K Item 2.02 (results) | $2.11 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $1.38 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $0.62 |
| May 8, 2025 | 8-K Item 2.02 (results) | $0.46 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $1.31 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $1.51 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALXO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.